Sitryx Therapeutics announced positive topline results from a Phase 1b trial of SYX-5219, a first-in-class oral pyruvate ...
Adults with chronic hand eczema (CHE) treated within the Duke University Health System reported substantial work productivity ...
An analysis of 633 skincare brands found gaps in evidence, safety information, and claim support, raising questions about ...
In "Case 2: Escalating Therapy After Biologic Failure in HS," the panel shifts to the series' second patient case.
A patient with 45 percent hair loss and a wedding in six months illustrates why psychosocial burden can reclassify disease ...
Can “Botox in a bottle” really rival injectable neuromodulators? We examine the evidence behind topical peptide serums and Argireline. From viral skin care hacks to trendy treatment devices, social ...
Cosibelimab (Unloxcyt; Sun Pharma), a PD-L1 inhibitor, is also approved for locally advanced and metastatic cutaneous ...
Christophe Piketty discusses 3-year ARCADIA data demonstrating sustained efficacy and long-term safety of nemolizumab in ...
The DecisionDx-Melanoma 31-GEP test recently released top data from the largest prospective GEP study. The study was ...
Sequencing Cryotherapy, Topicals, and PDT in Actinic Keratosis. Bhatia said comprehensive management of actinic keratosis has ...
Dr. Bunick introduces the panel's second case: a 72-year-old retired school administrator with plaque psoriasis diagnosed at ...
Hsiao noted the options are adalimumab, a tumor necrosis factor α inhibitor; secukinumab, an IL-17A inhibitor; and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results